Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polska Grupa Hutnicza's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Polska Grupa Hutnicza's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Polska Grupa Hutnicza's highest Yield on Cost was 36.40. The lowest was 8.06. And the median was 10.03.
WAR:PGH's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.29 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Polska Grupa Hutnicza (WAR:PGH) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Polska Grupa Hutnicza 5-Year Yield-on-Cost % Related Terms
WAR:PGH vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Polska Grupa Hutnicza's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polska Grupa Hutnicza 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Polska Grupa Hutnicza's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Polska Grupa Hutnicza's 5-Year Yield-on-Cost % falls into.
Polska Grupa Hutnicza 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Polska Grupa Hutnicza (WAR:PGH) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Polska Grupa Hutnicza and its competitors. Over the past decade, Polska Grupa Hutnicza's 5-Year Yield-on-Cost % has ranged from 8.06 to 36.40. According to the industry distribution chart, Polska Grupa Hutnicza ranks #999999 out of 513 companies in the Drug Manufacturers industry.
Is Polska Grupa Hutnicza's 5-Year Yield-on-Cost % too high?
Polska Grupa Hutnicza's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 8.06 to a high of 36.40. Based on the distribution chart, Polska Grupa Hutnicza ranks #999999 out of 513 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Polska Grupa Hutnicza has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Polska Grupa Hutnicza's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Polska Grupa Hutnicza ranks #999999 out of 513 companies for 5-Year Yield-on-Cost %. This places Polska Grupa Hutnicza in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.29. Historically, Polska Grupa Hutnicza's own 5-Year Yield-on-Cost % has ranged from 8.06 to 36.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.29, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Polska Grupa Hutnicza and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polska Grupa Hutnicza's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polska Grupa Hutnicza stock overvalued right now?
Based on GuruFocus' analysis, Polska Grupa Hutnicza (WAR:PGH) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.31, compared to a current price of zł3.60 — trading 1061.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Polska Grupa Hutnicza's overall GF Score™ is 30/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Polska Grupa Hutnicza (WAR:PGH), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polska Grupa Hutnicza (WAR:PGH) Overvalued in 2026?
Based on GuruFocus' analysis, Polska Grupa Hutnicza stock appears to be overvalued.
The current stock price of zł3.60 is trading 1061.3% above its estimated GF Value™ of zł0.31.
GuruFocus considers Polska Grupa Hutnicza to be Significantly Overvalued.
Key valuation signals for WAR:PGH:
5-Year Yield-on-Cost %: 0.00
GF Value™: zł0.31 vs. price of zł3.60 (1061.3% above fair value)
No single metric tells the full story. See the WAR:PGH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemp & Health SA is engaged in hemp and cannabis cultivation. The company processes harvested crops such as CBD and CBG, used for the production of white labels and private labels oils, creams, dried herbs and liquids for vaporization.
30GF Score
Get the complete analysis for WAR:PGH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PGH has been successfully added to your 
